BIT's 15^th Annual Congress of International Drug Discovery Science and Technology-Japan 2017 (IDDST-Japan 2017) which was held in Hyatt Regency Osaka, Osaka, Japan on July 25-27, achieved a consummation. The theme of this conference is “Dedicated to Accelerating Drug Innovation". Over 400 honored guests presented at the ceremony and gave brilliant speeches on invitation, among them are 2010 Nobel Prize Laureate in Chemistry Dr. Ei-ichi Negishi, H. C. Brown Distinguished Professor of Chemistry in Purdue University; Dr. Howard J. Federoff, Vice Chancellor of Health Affairs and Chief Executive Officer of Health System in University of California, Irvine; Dr. Litao Zhang, Vice President of Bristol-Myers Squibb; Dr. Jan Hoflack, Chief Scientific and Operational Officer of Oncodesign SA; Dr. Akiyoshi Suganuma, Group Officer and President of BA-CFU in Medicine Development Center, Eisai Co., Ltd., Dr. David C. Bunton, CEO of REPROCELL Europe Ltd. …etc.

This annual congress comprised 7 Parts and 38 sessions following the ceremony, including “Pharmacology and Toxicology"; "Medicinal Chemistry and Drug Design"; “Technologies in Drug Discovery"; “Advanced Drug Delivery"; "Traditional Therapies and Natural Products"; "From Disease Basic Science to Drug Development and Application"; "Young Scientist Forum"…etc.

This annual conference brought together 400 specialists from 54 countries and areas, which was devoted to the leading issues and popular topics and provide up-to-date information to all over the world. In welcome banquet, all guests appreciated and joined in the brilliant Japanese traditional performances, also expressed sincerely congratulation to successful IDDST-Japan 2017. Depending on the warmly support and good suggestions from all of the participants, we are quite confident in organizing IDDST-2018 which would be better and more successful than IDDST-Japan 2017. All of us are looking forward to meeting you again in 2018.